Adis | Diabetic Retinopathy: Current Pharmacologic Treatment And Emerging Strategies (2017 EN)

Discussion in 'Medicine' started by Kanka, Apr 10, 2017.

  1. Kanka

    Kanka Well-Known Member Loyal User

    Messages:
    16,047
    Likes Received:
    449
    Trophy Points:
    83
    [​IMG]

    Author: Michael W. Stewart
    Full Title: Diabetic Retinopathy: Current Pharmacologic Treatment And Emerging Strategies
    Publisher: Adis; 1st ed. 2017 edition (May 6, 2017)
    Year: 2017
    ISBN-13: 9789811035098 (978-981-10-3509-8), 9789811035081 (978-981-10-3508-1)
    ISBN-10: 9811035091, 9811035083
    Pages: 268
    Language: English
    Genre: Internal Medicine
    File type: PDF (True)
    Quality: 10/10
    Price: 114.39 €


    A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets.

    Existing therapeutic options are covered in depth, with a major focus on anti-vascular endothelial growth factor drugs and sustained release corticosteroids, including a review of trial results supporting current treatment guidelines. The use of agents off-label is also discussed. Controversial topics are discussed in detail with an emphasis on helping the reader make informed decisions, particularly when treating patients for which several treatment approaches may be appropriate because trial data does not clearly define the best option.

    Emerging therapeutic areas are evaluated, as work continues to identify agents that produce superior morphologic responses and visual acuity gains by targeting other molecules that contribute to diabetic retinopathy. Promising new drugs, targets and delivery systems are identified, and their development analysed.

    -------------
     
    Last edited by a moderator: Nov 26, 2019